E. D. BATU AKAL And A. ERDEN, "The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?," International Journal of Rheumatic Diseases , vol.26, no.8, pp.1435-1439, 2023
BATU AKAL, E. D. And ERDEN, A. 2023. The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?. International Journal of Rheumatic Diseases , vol.26, no.8 , 1435-1439.
BATU AKAL, E. D., & ERDEN, A., (2023). The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?. International Journal of Rheumatic Diseases , vol.26, no.8, 1435-1439.
BATU AKAL, EZGİ, And ABDULSAMET ERDEN. "The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?," International Journal of Rheumatic Diseases , vol.26, no.8, 1435-1439, 2023
BATU AKAL, EZGİ D. And ERDEN, ABDULSAMET. "The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?." International Journal of Rheumatic Diseases , vol.26, no.8, pp.1435-1439, 2023
BATU AKAL, E. D. And ERDEN, A. (2023) . "The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?." International Journal of Rheumatic Diseases , vol.26, no.8, pp.1435-1439.
@article{article, author={EZGİ DENİZ BATU AKAL And author={ABDULSAMET ERDEN}, title={The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?}, journal={International Journal of Rheumatic Diseases}, year=2023, pages={1435-1439} }